Meclofenamic acid

Meclofenamic acid (Meclofenamate) is a non-steroidal anti-inflammatory agent. Meclofenamic acid is a highly selective FTO (fat mass and obesity-associated) enzyme inhibitor. Meclofenamic acid competes with FTO binding for the m (6) A-containing nucleic acid. Meclofenamic acid is a non-selective gap-junction blocker. Meclofenamic acid inhibits hKv2.1 and hKv1.1, with IC50 values of 56.0 and 155.9 μM, respectively[1][2][3][4].

Product Specifications

CAS Number

[644-62-2]

Product Name Alternative

Meclofenamate

UNSPSC

12352005

Hazard Statement

H301

Target

Endogenous Metabolite; Fat Mass and Obesity-associated Protein (FTO) ; Gap Junction Protein; Potassium Channel

Type

Reference compound

Related Pathways

Cytoskeleton; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Metabolic Disease; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/meclofenamic-acid.html

Purity

99.66

Solubility

DMSO : 100 mg/mL (ultrasonic) |Methanol : 7.14 mg/mL (ultrasonic)

Smiles

O=C(O)C1=CC=CC=C1NC2=C(Cl)C=CC(C)=C2Cl

Molecular Formula

C14H11Cl2NO2

Molecular Weight

296.15

Precautions

H301

References & Citations

[1]Conroy MC, et al. Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium. Clin J Pain. 1991;7 Suppl 1:S44-8.|[2]Eleftheriou CG, et al. Meclofenamic acid improves the signal to noise ratio for visual responses produced by ectopicexpression of human rod opsin. Mol Vis. 2017 Jun 16;23:334-345. eCollection 2017.|[3]Huang Y, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015 Jan;43 (1) :373-84.|[4]Lee YT, et al. Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid. Eur J Pharmacol. 1999 Aug 13;378 (3) :349-56.